In addition, blocking the myeloid checkpoint of Signal regulatory protein alpha (SIRPα)/CD47 has shown to be efficient improving tumor phagocytosis and thus decreasing tumor burden (71, 72). The gene discussed is SIRPA; the disease is neoplasm.